Analogue Y
ID: ALA606551
PubChem CID: 46878349
Max Phase: Preclinical
Molecular Formula: C23H44N4O15
Molecular Weight: 616.62
Molecule Type: Small molecule
Associated Items:
This compound is not in our inventory system
ID: ALA606551
PubChem CID: 46878349
Max Phase: Preclinical
Molecular Formula: C23H44N4O15
Molecular Weight: 616.62
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC[C@H]1O[C@H](O[C@H]2[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3O)[C@@H](O)[C@H](N)C[C@@H]2N)[C@H](N)[C@H](O)[C@@H]1O
Standard InChI: InChI=1S/C23H44N4O15/c24-2-7-12(31)14(33)10(27)21(37-7)40-18-6(26)1-5(25)11(30)20(18)42-23-17(36)19(9(4-29)39-23)41-22-16(35)15(34)13(32)8(3-28)38-22/h5-23,28-36H,1-4,24-27H2/t5-,6+,7-,8-,9-,10-,11+,12-,13+,14+,15+,16-,17-,18-,19-,20+,21-,22+,23+/m1/s1
Standard InChI Key: OHLHHZLWYQBRLE-NQFPFFRUSA-N
Molfile:
RDKit 2D 42 45 0 0 0 0 0 0 0 0999 V2000 -4.3018 0.6723 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.9692 0.1874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.7143 -0.5972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.8893 -0.5972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6344 0.1874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.1992 -1.2646 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.4044 -1.2646 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -5.7538 0.4423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8497 0.4423 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.2669 1.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6795 2.4013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5045 2.4013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9170 1.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5045 0.9723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6795 0.9723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.7420 1.6868 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.1545 2.4013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.7420 3.1157 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.1545 3.8302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.9795 3.8302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3920 3.1158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.9795 2.4013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3920 1.6868 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.2670 0.2578 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.4419 1.6868 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.9170 3.1157 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.7420 4.5447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3920 4.5447 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -6.2170 3.1158 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.1545 5.2592 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -6.3669 -0.1097 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.8637 -2.0183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6261 -2.7328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0386 -2.0183 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -5.2762 -2.7328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.8637 -3.4472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0386 -3.4472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8011 -2.7328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6261 -4.1617 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -5.2761 -4.1617 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -6.1012 -2.7328 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.3886 -3.4472 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 1 5 1 0 2 3 1 0 3 4 1 0 4 5 1 0 3 6 1 6 4 7 1 6 2 8 1 1 5 9 1 1 10 11 1 0 15 10 1 0 11 12 1 0 12 13 1 0 13 14 1 0 14 15 1 0 14 9 1 6 13 16 1 6 17 16 1 6 17 18 1 0 22 17 1 0 18 19 1 0 19 20 1 0 20 21 1 0 21 22 1 0 22 23 1 6 15 24 1 6 10 25 1 1 12 26 1 1 19 27 1 1 20 28 1 6 21 29 1 6 27 30 1 0 8 31 1 0 32 6 1 6 34 32 1 0 32 35 1 0 33 34 1 0 37 33 1 0 35 36 1 0 36 37 1 0 33 38 1 6 37 39 1 6 36 40 1 6 35 41 1 1 38 42 1 0 M END
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 616.62 | Molecular Weight (Monoisotopic): 616.2803 | AlogP: -8.83 | #Rotatable Bonds: 9 |
Polar Surface Area: 341.53 | Molecular Species: BASE | HBA: 19 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 19 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.02 | CX Basic pKa: 9.59 | CX LogP: -8.20 | CX LogD: -13.05 |
Aromatic Rings: ┄ | Heavy Atoms: 42 | QED Weighted: 0.11 | Np Likeness Score: 1.30 |
1. Cashman DJ, Rife JP, Kellogg GE.. (2001) Which aminoglycoside ring is most important for binding? A hydropathic analysis of gentamicin, paromomycin, and analogues., 11 (2): [PMID:11206440] [10.1016/s0960-894x(00)00615-6] |
Source(1):